Bell Christopher is categorized under Internal Medicine Doctors in Corvallis, OR and active since 2010.
Bell Christopher was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6213993 by the NAICS.
If you are seeking more information, feel free to contact Christopher Bell at the company’s single location by writing to 3680 Nw Samaritan Drive, Corvallis, Oregon OR 97330 or by phoning (541) 754-1988. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bell Christopher |
| Contact Person: | Christopher Bell |
| Address: | 3680 Nw Samaritan Drive, Corvallis, Oregon 97330 |
| Phone Number: | (541) 754-1988 |
| Website Address: | corvallisclinic.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6213993 |
| Share This Business: |
Bell Christopher was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6213993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Bell for inquiries that concern Bell Christopher by calling the company number (541) 754-1988, as your correspondence is most welcome. Additionally, the physical location of the single location of Bell Christopher can be found at the coordinates 44.604504,-123.25097 as well as the street address 3680 Nw Samaritan Drive in Corvallis, Oregon 97330.
For its online presence, you may visit Bell Christopher’s website at corvallisclinic.com and engage with its social media outlets through on Twitter and on Facebook.